Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.38 |
| ▸ | HTR2B | P41595 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17375754 | 1.00 | IDO1 (0.44) | IDO1TDP1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL6990568 | 0.80 | MEN1 (0.38) | IDO1CYP2D6CYP2C9MAPK1CYP2C19 | |
| Chlorobenzene SCHEMBL27657978 | 0.74 | CYP2D6 (0.37) | CYP2D6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1170735 | 0.73 | TDP1 (0.49) | IDO1TDP1TP53TSHRSMN1; SMN2 | |
| SCHEMBL38651360 | 0.72 | IDO1 (0.60) | IDO1TSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL11295933 | 0.72 | CHRM2 (0.42) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL28184514 | 0.72 | ALDH1A1 (0.39) | CYP1A2LMNAALDH1A1 | |
| SCHEMBL3687682 | 0.71 | IDO1 (0.44) | IDO1TSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL151181 | 0.71 | IDO1 (0.44) | IDO1TSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL15571725 | 0.71 | IDO1 (0.52) | IDO1TDP1CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170157301-A1 | LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS | TECHNISCHE UNIVERSITÄET WIEN (AT) | 2017-06-08 | — | — | US | disclosed |
| EP-3160462-A1 | LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS | Technische Universität Wien (AT) | 2017-05-03 | — | — | EP | disclosed |
| WO-2015196228-A1 | LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2015-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157301-A1 | LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS | CCNH, MYLK, CCAR2 | IDO1 3269/4885TDP1 4649/4885CYP1A2 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.